Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Is There a Difference in the Mortality Prediction Performance of Two ICISS Approaches for Trauma Patients Admitted to Hospitals in Urban India?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02715739
Recruitment Status : Completed
First Posted : March 22, 2016
Last Update Posted : February 28, 2017
Sponsor:
Collaborators:
Tata Institute of Social Sciences
King Edward Memorial Hospital
Lokmanya Tilak Municipal Medical College and Hospital
Jai Prakash Narayan Apex Trauma Center
Seth Sukhlal Karnani Memorial Hospital
Information provided by (Responsible Party):
Martin Gerdin, Karolinska Institutet

Brief Summary:
This study aims to compare the predictive performance of two different approaches of the international classification of disease injury severity score (ICISS) using data from four public university hospitals in urban India.

Condition or disease Intervention/treatment
Wounds and Injuries Other: No intervention

Show Show detailed description

Layout table for study information
Study Type : Observational
Actual Enrollment : 3921 participants
Observational Model: Cohort
Time Perspective: Retrospective
Study Start Date : January 2016
Actual Primary Completion Date : January 2017
Actual Study Completion Date : January 2017

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
All participants Other: No intervention



Primary Outcome Measures :
  1. Mortality [ Time Frame: Within 30 days of patient arrival to participating centre ]

Secondary Outcome Measures :
  1. Mortality [ Time Frame: Within 24 hours of patient arrival to participating centre ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Trauma patients admitted to participating centres.
Criteria

Inclusion criteria

  • All admitted patients that presented with history of trauma and were alive at arrival to any of the studied hospitals.
  • Patients who died after arrival but before admittance were also included.

Exclusion criteria

  • Eligible patients with isolated limb injury, i.e. isolated extremity fractures without vascular injury were not included.
Layout table for additonal information
Responsible Party: Martin Gerdin, Researcher, Karolinska Institutet
ClinicalTrials.gov Identifier: NCT02715739    
Other Study ID Numbers: mattias-attergrim-201603131327
First Posted: March 22, 2016    Key Record Dates
Last Update Posted: February 28, 2017
Last Verified: February 2017
Keywords provided by Martin Gerdin, Karolinska Institutet:
Trauma
India
ICISS
Additional relevant MeSH terms:
Layout table for MeSH terms
Wounds and Injuries